Clinical Trials & COVID-19
About the Study
CT-5080 Study 101
CT-0508 in Combination with Pembrolizumab Substudy
HER2 Overexpression in Solid Tumors
About Clinical Trials
See if you
Does your tumor overexpress HER2?
If so, consider joining the CT0508 Study 101, a clinical trial researching macrophage cell therapy as a new potential treatment in solid tumors over expressing HER2.
CT-0508 Study 101 Overview
CT-0508 in combination with Pembrolizumab Substudy Overview
Take the short pre-screener to see if you may qualify!
Terms and Conditions